CIC BiomaGUNE
Centro (uo)
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (31)
2024
-
Self-assembly of NrTP6 cell-penetrating lipo-peptide with variable number of lipid chains: Impact of phosphate ions on lipid association
Journal of Colloid and Interface Science, Vol. 654, pp. 124-133
2023
2022
-
Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
Biomedicines, Vol. 10, Núm. 5
-
N-Glycans in Immortalized Mesenchymal Stromal Cell-Derived Extracellular Vesicles Are Critical for EV–Cell Interaction and Functional Activation of Endothelial Cells
International Journal of Molecular Sciences, Vol. 23, Núm. 17
-
Protocols for the Evaluation of Neurodevelopmental Alterations in Rabbit Models In Vitro and In Vivo
Frontiers in Toxicology, Vol. 4
2021
-
Detection of cytokines in skeletal muscle tissue using optical SPR sensing platform
Proceedings of the 2021 13th Spanish Conference on Electron Devices, CDE 2021
-
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease
Theranostics, Vol. 11, Núm. 13, pp. 6542-6559
-
Structural Brain Changes during the Neonatal Period in a Rabbit Model of Intrauterine Growth Restriction
Developmental Neuroscience, Vol. 42, Núm. 5-6, pp. 217-229
-
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 226
2020
-
An Assay for Screening Potential Drug Candidates for Alzheimer's Disease That Act as Chaperones of the Transthyretin and Amyloid-β Peptides Interaction
Chemistry - A European Journal, Vol. 26, Núm. 72, pp. 17462-17469
-
Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery
Journal of Medicinal Chemistry, Vol. 63, Núm. 6, pp. 3205-3214
-
Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study
Journal of Alzheimer's Disease, Vol. 77, Núm. 1, pp. 99-112
-
Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation
Nature Immunology, Vol. 21, Núm. 2, pp. 135-144
2019
-
Assisted delivery of anti-tumour platinum drugs using DNA-coiling gold nanoparticles bearing lumophores and intercalators: Towards a new generation of multimodal nanocarriers with enhanced action
Chemical Science, Vol. 10, Núm. 40, pp. 9244-9256
-
Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD
Scientific Reports, Vol. 9, Núm. 1
2018
-
Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene
Neurobiology of Disease, Vol. 110, pp. 206-217
-
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, Núm. 2, pp. 339-351
2017
-
Building Bridges through Science
Neuron
-
Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal
Journal of Medicinal Chemistry, Vol. 60, Núm. 13, pp. 5749-5758